• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine HCL

    FDA

    Purdue Pharma partners with MMCAP Infuse to provide low-cost opioid use disorder

    PHARMABIZ

    Enforcement Report - Week of November 15, 2023

    FDA

    Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice

    PR NEWSWIRE

    Sun Pharma`s Generic Buprenorphine & Naloxone Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Suboxone settlement boosts Dr. Reddy’s Q1 net

    THE HINDU

    Unveiling of three new and innovative products of Temad company

    PRESS RELEASE

    Aveva`s Generic Buprenorphine HCL Naloxone HCL Receives Approval in the U.S.

    FDA

    Alvogen`s Generic Buprenorphine HCl Receives Approval In US

    FDA

    Alkem`s Generic Buprenorphine HCl; Naloxone HCl Receives Approval In US

    FDA

    Indivior to pay $600m to settle opioid drug marketing claims

    PHARMACEUTICAL-TECHNOLOGY

    Indivior to Pay $10M to Consumers, Settling FTC Charges that Company Illegally Maintained a Monopoly-Opioid Addiction Suboxone

    FTC

    Camurus Announces Submission of Request for Final Approval of Brixadi™

    PRNEWSWIRE

    Coronavirus opens access to online opioid addiction treatment

    FIERCE BIOTECH

    Premier Pharmacy Labs Issues Voluntary Nationwide Recall of all Unexpired Sterile Drug Product Lots Due to Lack of Sterility Assurance

    FDA

    Alvogen`s Generic Buprenorphine Hydrochloride Receives Tentative Approval in US

    FDA

    Spectrum Laboratory Products Receives FDA Warning Letter

    FDA

    In states with most overdose deaths, poor patients struggle to find treatment

    REUTERS

    Alvogen`s Generic Buprenorphine HCl; Naloxone HCl Receives Approval in US

    FDA

    Dr Reddy`s Labs hits 52-week high; stock rallies 5% in two days

    BUSINESS STANDARD

    British drugmaker Indivior`s shares hit by copycat, new drug worries

    REUTERS

    Dr. Reddys Labs Generic Buprenorphine Hydrochloride: Naloxone Hydrochloride Receives Approval In US

    FDA

    Mylan Technologies Generic Buprenorphine Hydrochloride : Naloxone Hydrochloride Receives Approval In US

    FDA

    Suboxone®(buprenorphine HCL & Naloxone HCL) :Indivior v.Teva Pharmaceuticals USA

    PATENT LITIGATION

    Suboxone®(buprenorphine HCL & Naloxone HCL) : Indivior v. Alvogen Pine Brook

    PATENT LITIGATION

    Suboxone®(buprenorphine HCL & Naloxone HCL): Indivior v. Par Pharmaceutical

    PATENT LITIGATION

    FDA to boost drug therapy for addicts

    NWA ONLINE

    Suboxone® (buprenorphine HCL & naloxone HCL):Indivior v. Teva Pharmaceuticals

    PATENT LITIGATION

    Suboxone® (buprenorphine HCL & naloxone HC):Indivior v. Par Pharmaceutical

    PATENT LITIGATION

    Suboxone® (buprenorphine HCL & naloxone HCL):Indivior v. Dr. Reddy`s Laboratories

    PATENT LITIGATION

    Suboxone® (buprenorphine HCL & naloxone HCL)): Indivior v. Actavis Laboratories

    PATENT LITIGATION

    Mundipharma Corporation Limited Zubsolv buprenorphine / Naloxone Receives Approval In Europe

    EMA

    Indivior reaches settlement with Mylan over patent dispute

    PHARMAFILE

    FDA Confirms Paragraph IV Patent Challenge of Zubsolv (Buprenorphine Hydrochloride & Naloxone Hydrochloride Dihydrate Sublingual Tablets)

    PRESS RELEASE

    FDA Confirms Paragraph IV Patent Challenge of Bunavail (Buprenorphine and Naloxone Buccal Film)

    FDA

    BioDelivery Sciences gets expanded US patent protection-Belbuca,Bunavail&Onsolis

    PHARMABIZ

    Rhodes Pharm’s Generic Buprenorphine Hydrochloride Receives Approval US

    FDA

    Orexo`s Zubsolv (Buprenorphine Hcl; Naloxone Hcl) Receives Supplemental Approval in US

    Kremers Urban Pharms Generic Buprenorphine Hydrochloride Approved In US

    FDA

    Sun Pharm ANDA Buprenorphine Hydrochloride & Naloxone Hydrochloride

    FDA

    Titan`s Generic Buprenorphine Hydrochloride approved in US for Opioid addiction

    FDA

    Analyzing Data for Earliest Market Entry for Subsequent ANDA Filers

    TWOFOUR INSIGHT

    Sun Pharma`s Generic Buprenorphine HCl approved in US as opioid analgesic

    FDA

    Former Greyhealth and CDM executives launch Minds + Assembly

    MMM

    Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management

    PR NEWS WIRE

    BioDelivery Sciences Secures Exclusive Preferred Formulary Status for BUNAVAIL® with Tennessee Medicaid (TennCare)

    PR NEWS WIRE

    Orexo AB (ORXOF) Wins FDA Approval for ZUBSOLV

    BIOSPACE

    In Case You Missed It ,We Did! Prometheus Takes Action Against FDA Over Generic LOTRONEX Approval...

    FDA LAW BLOG

    Suboxone: What is the drug linked to Charleston shooting suspect?

    FOX 8

    Sandoz` Generic Buprenorphine Hcl (Eq 2Mg Base) Approved in US For Opioids Dependence and Pain

    FDA

    Actavis Elizabeth`s Generic Buprenorphine Hydrochloride (Buprenorphine Hydrochloride 2Mg, 8Mg) Approved in USA for Narcotic Addiction

    FDA

    Biodelivery`s Bunavail (Buprenorphine Hydrochloride/ Naloxone Hydrochloride) Receives Supplemental Approval in USA for Opioid Dependence

    FDA

    Orexo AB`s Zubsolv (Buprenorphine Hydrochloride/ Naloxone Hydrochloride) Receives Supplemental Approval in USA for Opioid Dependence

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.